POLE Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability (NCT03428802) | Rutgers, The State University of New Jersey | 2018-03-08 |
Track POLE Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.